Inaugural GI Oncology Symposium - Exhibit Registration

Houston, TX US
December 6, 2024

EXHIBITOR/SPONSOR REGISTRATION

You are NOT confirmed to exhibit until you register.

Registration deadline: November 22, 2024

 

Dear Corporate Partner,

It is our pleasure to invite you to exhibit at our Inaugural GI Oncology Symposium at the Houston Methodist Research Institute on Friday, December 6, 2024. On behalf of our Course Director, Dr. Maen Abdelrahim and the Office of Continuing Medical Education (CME) we graciously extend the opportunity for you to join us as an exhibitor and/or sponsor!

We estimate that this annual conference will attract approximately 100 in-person attendees and virtual attendees – all potential customers for your products and services.

I encourage you to take full advantage of this excellent opportunity to network with your target market as an exhibitor. Exhibiting companies will have the opportunity to share their educational materials and interact with participants.

Due to our limited number of exhibit openings, we hope you will take this opportunity and contact us now to register.

Please feel free to contact amshupak@houstonmethodist.org if you have any questions or need additional information.

Sincerely,

Maen Abdelrahim, MD, PhD, PharmB
Associate Professor of Medicine, Academic Institute
Associate Clinical Member, Research Institute
Director, Cockrell Center for Advanced Therapeutics, Research Institute
Houston Methodist
Weill Cornell Medical College

EXHIBIT DETAILS

Date and Time
Friday, December 6, 2024 | 8:00am – 3:00pm

Exhibit Location
Houston Methodist Research Institute
6670 Bertner Ave.
2nd Floor Pre-Function Space
Houston, TX 77030

EXHIBIT FEE: $1,000

  • One 6’ x 3’ table-top exhibit with two chairs
  • Exhibiting companies may send a maximum of two (2) representatives to staff their exhibit table.
  • Recognition in the webpage and activity materials

SPONSORSHIP FEE OPTIONS

  • BREAK SPONSOR: $1,800 - Recognition in activity materials and signage during break as Sponsor.
  • BREAKFAST SPONSOR: $2,700- Recognition in activity materials and signage during breakfast as Sponsor.
  • LUNCH SPONSOR: $4,500- Recognition in activity materials and signage during lunch as Sponsor. 

NOTE: Companies may purchase one exhibit and one sponsorship type.

Course summary
Course opens: 
08/12/2024
Course expires: 
12/06/2024
Event starts: 
12/06/2024 - 8:00am CST
Event ends: 
12/06/2024 - 3:00pm CST

TIME

PRESENTATION

SPEAKERS

 

8:00 AM –8:25 AM

 

                              Light Breakfast and Registration

 

8:25 AM – 8:30 AM

 

Welcome and Introduction

 Jenny C. Chang, MD

 Director, Dr. Mary and Ron Neal Cancer Center

 

 Maen Abdelrahim, MD, PhD, Pharm B

Section Chief of Gastrointestinal Medical Oncology, Dr.  Mary and Ron Neal Cancer Center

 

8:30 AM –8:35 AM

Session 1: Hepatobiliary Cancer

Maen Abdelrahim, MD, PhD, Pharm B, MD, Karim J. Halazun, MD and Milind Javle, MD, and Aiwu Ruth He, MD, Mazen Noureddin, MD, MHSc

 

8:35 AM –8:45 AM

Worldwide Epidemiology and United States Burden of Liver Cancers: Risk Factors and Prevention

 Hashem B. El-Serag, MD, MPH

 8:45 AM –8:55 AM

Pathogenesis and Surveillance Modalities of Hepatobiliary Cancer

  Amit Singal, MD, MS

 8:55 AM –9:05 AM

Current Status of Pre-Liver Cancer Diseases: Management and Future Directions  

  Mazen Noureddin, MD, MHSc

 

9:05 AM –9:10 AM

 

                                                Break

 9:10 AM – 9:20 AM

Transplant-Bridging Approaches in Hepatocellular Carcinoma

  Maen Abdelrahim, MD, PhD, Pharm B

 

9:20 AM – 9:30 AM

Updates on Operative Approaches in Early-Stage Hepatobiliary Cancer

 

Karim J. Halazun, MD

 

9:30 AM – 9:40 AM

New Frontiers for Immunotherapy in Patients with Advanced and Resectable Hepatocellular Carcinoma

  Ahmed Kaseb, MD

 

 9:40 AM – 9:50 AM

Current and Emerging Management in Advanced Cholangiocarcinoma

   Milind Javle, MD

  9:50 AM –10:15 AM

Panel Discussion

Maen Abdelrahim, MD, PhD, Pharm B (moderator) Aiwu Ruth He, MD, Mazen Noureddin, MD, MHSc, and Ahmed Kaseb, MD, Karim J. Halazun, MD, Hashem B. El-Serag, MD, MPH, Milind Javle, MD

10:15 AM –10:20 AM

Session 2: Pancreatic & Neuroendocrine Cancer

 Anwaar Saeed, MD, Nestor F. Esnaola, MD, MPH, MBA, FACS, and Philip A Philip, MD

10:20 AM – 10:30 AM

 Updates on Molecular Diagnostics

Mary R. Schwartz, MD

10:30 AM – 10:40 AM

 Updates on Operative and Perioperative Approaches in Pancreatic   Adenocarcinoma

Nestor F. Esnaola, MD, MPH, MBA, FACS

10:40 AM – 10:50 AM

 Targeted Therapy Developments in Advanced-Stage Pancreatic Adenocarcinoma

Mohammed Alghamdi, MD, MBA

10:50 AM – 11:00 AM

 Updates in the Management of Low-/Intermediate-Grade Neuroendocrine Carcinoma

Philip A Philip, MD

 

11:00 AM – 11:15 AM

 

  

Panel Discussion

Anwaar Saeed, MD, Nestor F. Esnaola, MD, MPH, MBA, FACS, and Philip A Philip, MD, Mary R. Schwartz, MD

11:15 AM – 11:55 AM

 Keynote: Integrating Immunotherapy into the Neoadjuvant Space in Gastrointestinal Malignancies: A Shifting Paradigm

James P. Allison, Ph. D

 

11:55 AM – 12:00 PM

 

Session 3: Colorectal Cancer

Eric Haas, MD, and Monisha Singh, MD, Maen Abdelrahim, MD, PhD, Pharm B

12:00 AM – 12:10 PM

 Updates in the Management of Colorectal Liver Metastases

Kirk Heyne, MD

12:10 AM – 12:20 PM

 Advancement in Surgical Management in Colorectal Cancer

Eric Haas, MD

12:20 AM – 12:30 PM

 Immunotherapy Developments in Colorectal Cancer, MSI-H

 Anaum Maqsood, MD

12:30 AM –12:40 PM

 Immunotherapy Developments in Colorectal Cancer, MSS

   Ali Alqahtani, MD

12:40 PM – 12:50 PM

 Precision Medicine Developments in Colorectal Cancer

Aiwu Ruth He, MD, PhD

 

12:50 PM – 01:10 PM

 

 

Panel Discussion

 

 

Joshua C. Coursey, MD (moderator) Anaum Maqsood, MD, Eric Haas, MD, and Kirk Heyne, MD

01:00 PM – 02:00 PM

                         Networking Reception/Lunch

 

02:00 PM – 02:05 PM

 

Session4: Esophageal and Gastric Cancer

 Aiwu Ruth He, MD, PhD, Fadi I. Abu-Shahin, MD, and Anaum Maqsood, MD

02:05 PM – 02:15 PM

 Advances in Multidisciplinary Approaches in Resectable Gastric/Esophageal Cancer

 Anwaar Saeed, MD

 

02:15 PM – 02:25 PM

 Immunotherapy Advancements and Predictive Markers in Unresectable Gastroesophageal Adenocarcinoma

Fahad Ibnshamsah, MD

02:25 PM – 02:35 PM

 Precision Medicine Advancements in Unresectable Gastroesophageal Adenocarcinoma

 Monisha Singh, MD

 

 

02:35 PM – 02:55 PM

 

Panel Discussion

 Monisha Singh, MD, (moderator)Fadi I. Abu-Shahin, MD, Fahad Ibnshamsah, MD and Anwaar Saeed, MD

 

02:55 PM – 03:00 PM

Concluding Remarks

Cochair

 

Houston Methodist Research Institute
6670 Bertner Avenue
John F. Bookout Auditorium, 2nd Floor
Houston, TX 77030
United States

 

 

Please login or register to take this course.

Registration Instructions

  • STEP 1 - Select the applicable fee and add to cart to complete the checkout process.
  • STEP 2 - Once registered, on the week of the conference you will receive an email from Annie (amshupak@houstonmethodist.org) for more details on exhibiting.